|
The clinical trial includes Tykerb w/ Xeloda. The FDA should approve Tykerb around the end of 2006. At that point we'll be back to the "off label" scenerio, I'm sure.
There were rumors at ASCO that GSK will start adjuvant trials later this year.
Regards
Joe
|